TherapeuticsMD agrees to be acquired by EW Healthcare Partners

May 31, 2022 6:36 AM ETTherapeuticsMD, Inc. (TXMD)GSKBy: Dulan Lokuwithana, SA News Editor40 Comments

word m and a made with wood building blocks, stock image

Maks_Lab/iStock via Getty Images

  • Women’s healthcare company TherapeuticsMD (NASDAQ:TXMD) announced Tuesday that it reached an agreement to be acquired by an affiliate of private equity firm EW Healthcare Partners for $10 per share in an all-cash transaction.
  • TherapeuticsMD (TXMD) shares have added ~351% in the pre-market on the news.
  • Per the terms, EW Healthcare Partners is set to start a tender offer to acquire all outstanding shares of TXMD common stock at the agreed purchase price, immediately followed by a merger.
  • The buyout offer worth about $177M, including debt, represents a premium of 367.3% over the closing price of TherapeuticsMD (TXMD) shares on Friday.
  • The transaction is expected to close on or before July 13, 2022, subject to certain conditions.
  • Another pharma deal announced by U.K. pharma giant GlaxoSmithKline (GSK) made headlines on Tuesday.

Recommended For You

Comments (40)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.